Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) were named in the Boston Consulting Group’s list of the 50 most innovative companies this year at the 20 and 42 spot, respectively. Apple (NSDQ:AAPL) and Google (NSDQ:GOOG) took the top 2 spots on the list. Other notable entries were Gilead at number 8, Bayer‘s (ETR:BAYN) at 11, Biogen (NSDQ:BIIB) at […]
Medtronic
FDA approves Medtronic’s Activa DBS for conditional full-body MRI
Medtronic (NYSE:MDT) said today that its Activa line of deep-brain stimulators won FDA approval for conditional, full-body MRI scans, claiming the devices as the only examples allowed on the U.S. market for full-body MR imaging. The approval applies both to new Activa devices and to the roughly 43,000 U.S. patients already implanted with them, Fridley, Minn.-based […]
UW to lead expansion of Medtronic’s HeartRescue program
Medtronic (NYSE:MDT) said today that the University of Washington will lead a U.S. expansion of its HeartRescue program, which aims to improve survival rates for sudden cardiac arrest. Fridley, Minn.-based Medtronic launched HeartRescue in 2010 in 5 states, looking to train healthcare providers on resuscitation methods to boost the SCA survival rate, which has not moved […]
Patent board hands St. Jude Medical a win over patent troll
A U.S. patent board last week handed a win over a patent troll to St. Jude Medical (NYSE:STJ), ruling that several claims in a patent owned by Atlas IP LLC are unpatentable. Atlas, a so-called “non-practicing entity,” was pursuing infringement lawsuits against St. Jude, cross-town rival Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and Biotronik. In a Dec. 3 ruling, the U.S. Patent […]
Medtronic finally escapes Lenox MacLaren bone mill suit
A federal judge in Colorado dismissed an anti-trust lawsuit filed against Medtronic (NYSE:MDT) by bone mill maker Lenox MacLaren Surgical, ruling that Lenox failed to name the correct Medtronic subsidiary in the suit. Louisville, Colo.-based Lenox MacLaren 1st inked a distribution deal with Medtronic subsidiary Medtronic Sofamor Danek USA in 2000, hoping the pact would provide the scale to […]
Medtronic mulls sale of some Covidien assets
With 3 quarters of operations under its belt since the $50 billion acquisition of Covidien, Medtronic (NYSE:MDT) is evaluating whether to sell off some of the Covidien assets, CEO Omar Ishrak told analysts yesterday during a conference call. Ishrak said Covidien, which Medtronic calls its minimally invasive therapies group, has “a very clear and compelling vision for the future, […]
Report: TMVR at least 4 years from U.S. market
Transcatheter mitral valve replacements are at least 4 years out from hitting the U.S. market, despite the $2 billion recently dropped on companies developing the technology by some of the top names in medtech. Medtronic (NYSE:MDT), Abbott (NYSE:ABT), Edwards Lifesciences (NYSE:EW) and HeartWare International (NSDQ:HTWR) in recent months have spent a total of $2 billion to buy […]
Medtronic’s Q2 earnings beat estimates
Medtronic‘s (NYSE:MDT) fiscal 2nd-quarter earnings beat expectations as revenues met estimates, prompting the medical device leviathan to raise the low end of its profit forecast. Fridley, Minn.-based Medtronic posted profits of $520 million, or $1 per share, on sales of $7.06 billion for the 3 months ended Oct. 30. Compared with the same quarter last year, before […]
Diabetes: Medtronic taps Schein as exclusive U.S. distributor
Medtronic (NYSE:MDT) said today that it tapped Henry Schein (NSDQ:HSIC) to be its exclusive distributor for some Type II diabetes products in the U.S. Fridley, Minn.-based Medtronic said the Henry Schein Medical business will distribute the products to primary care physicians here, including its iPro2 Professional continuous glucose monitor and the i-Port Advance injection port. “Medtronic is committed […]
FDA: Class II recall for Medtronic’s InSync III pacemakers
A battery longevity issue prompted Medtronic this month warn doctors about some 96,787 of its InSync III pacemakers, an action the FDA labeled a Class II recall, although Medtronic said only about 22,000 of the devices are still active. The Fridley, Minn.-based medical device titan sent a letter to physicians dated November 2015, warning that a high […]
Danaher lures ex-Medtronic legal eagle Ellis for GC spot | Personnel Moves
Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May. Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE) “Brian brings a wealth of experience leading and […]